Stocks and Investing
Stocks and Investing
Fri, September 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Maintained (TVTX) at Strong Buy with Increased Target to $23 on, Sep 6th, 2024
Ed Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $20 to $23 on, Sep 6th, 2024.
Ed has made no other calls on TVTX in the last 4 months.
There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024
These are the ratings of the 4 analyists that currently disagree with Ed
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $20 on, Tuesday, August 13th, 2024
- Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 7th, 2024
Contributing Sources